Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
NexoBrid® (anacaulase-bcdb) – New orphan drug approval
December 29, 2022 - MediWound announced the FDA approval of NexoBrid (anacaulase-bcdb), for eschar removal in adults with deep partial thickness (DPT) and/or full thickness (FT) thermal burns.
